This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Novartis' initial stake in Nestlé's Alcon not subject to merger control in Europe

By Anne MacGregor and Justin Gibbs ( April 25, 2008, 08:55 GMT | Insight) -- The first stage of Novartis´ planned acquisition of Nestlé's stake in Alcon will not be notified in Brussels since the initial phase of this transaction (24.85 percent stake) does not amount to a 'concentration' within the meaning of the EC Merger Regulation.Novartis, Europe's second-largest pharmaceuticals company, announced on 7 April 2008 that it is set to buy Nestlé's majority stake in Alcon, the world leader in eye care, in a two step operation over the next three years....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login